Accendra Net Income Applicable To Common Shares from 2010 to 2026
| ACH Stock | USD 2.27 0.06 2.71% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -326.4 M | Current Value -310.1 M | Quarterly Volatility 139.1 M |
Check Accendra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accendra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 319.7 M, Interest Expense of 173.6 M or Total Revenue of 12.9 B, as well as many indicators such as Price To Sales Ratio of 0.0058, Dividend Yield of 0.0049 or PTB Ratio of 0.0884. Accendra financial statements analysis is a perfect complement when working with Accendra Health Valuation or Volatility modules.
Accendra | Net Income Applicable To Common Shares | Build AI portfolio with Accendra Stock |
The Net Income Applicable To Common Shares trend for Accendra Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Accendra Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Accendra Health's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Accendra Health over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Accendra Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Accendra Health's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Accendra Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (44,084,937) | |
| Geometric Mean | 37,361,497 | |
| Coefficient Of Variation | (315.45) | |
| Mean Deviation | 101,993,543 | |
| Median | 22,389,000 | |
| Standard Deviation | 139,066,614 | |
| Sample Variance | 19339.5T | |
| Range | 385.1M | |
| R-Value | (0.69) | |
| Mean Square Error | 10864.2T | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | (18,947,130) | |
| Total Sum of Squares | 309432.4T |
Accendra Net Income Applicable To Common Shares History
About Accendra Health Financial Statements
Investors use fundamental indicators, such as Accendra Health's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Accendra Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Loss | -326.4 M | -310.1 M |
Currently Active Assets on Macroaxis
When determining whether Accendra Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Accendra Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Accendra Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Accendra Health Stock:Check out the analysis of Accendra Health Correlation against competitors. For more detail on how to invest in Accendra Stock please use our How to Invest in Accendra Health guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Medical Distribution market expansion? Will Accendra introduce new products? Factors like these will boost the valuation of Accendra Health. If investors know Accendra will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Accendra Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Accendra Health requires distinguishing between market price and book value, where the latter reflects Accendra's accounting equity. The concept of intrinsic value—what Accendra Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Accendra Health's price substantially above or below its fundamental value.
Understanding that Accendra Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Accendra Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Accendra Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.